Gert Moelgaard is Head of Strategic Development at NNE Pharmaplan. (Bilder: NNE Pharmaplan)
The Future of Pharmaceutical Production?

The Process Validation Trend — Preparing for the Future

In January 2014 the "new" FDA process validation guide celebrated its 3 years anniversary - and in February the European Commission launched EMA's draft to a new European Annex 15 for Validation and Qualification in the GMPs. However, although Annex 15 is only a draft, we already know enough to prepare our validation and qualification approach for the future. Actually some of the new practices are already becoming regulatory expectations - sometimes with significant impact on observations or even warning letters for pharmaceutical companies.

Read on
 (Montage: PROCESS)
Gateway to Arabia

What Bahrain has in Store for the Process Industry

The caravan moves on — while markets like China and India took the spotlight during the last years, the Middle East is about to tap into its industrial resources. Major plant projects boom in states like Bahrain. Now wonder that the country was able to attract companies like BASF, Siemens, DHL and many others …

Read on
Rentschler Biotechnologie is a contract manufacturing organization (CMO) in biopharmaceuticals, creating products for larger firms that need to be manufactured on a small scale or within a very short time frame. (Picture: Quattroflow)
Diaphragm Pumps in Pharma

How to Choose the Right Pump for Biopharma Manufacture

Rentschler Biotechnologie has built a reputation as one of the biopharmaceutical industry’s top contract manufacturing organizations with the help of Quattroflow quaternary diaphragm pumps. In the company’s new single-use production facility, these pumps’ ability to operate with minimal pulsation helps to keep the process within validation boundaries, especially when it comes to minimizing pressure fluctuations during critical filtration steps.

Read on
Dow Executive Vice President Mike Gambrell: “This facility is very much in line with our equity-light strategy — a key component of Dow’s transformation into an earnings growth company.”  (Picture: Dow)
Chlor-Alkali

Dow and K2 Pure Announce Start-Up of Chlor-Alkali Facility at California Site

The Dow Chemical Company and K2 Pure Solutions (K2 Pure) have celebrated the successful start-up of a new chlor-alkali plant at Dow’s Pittsburg, California site. The new state-of-the-art manufacturing facility will produce bleach to serve municipal water treatment facilities in Northern California. In addition, the plant will supply Dow’s Pittsburg operations with chlorine for the manufacture of crop protection products and other materials.

Read on